Delaware Recognizes September 2026 as Prostate Cancer Awareness Month
Senate Concurrent Resolution 195 shines a statewide spotlight on prostate health — and on the fast, noninvasive screening technology helping men detect prostate cancer earlier.
Delaware has officially designated September 2026 as Prostate Cancer Awareness Month through Senate Concurrent Resolution 195, joining a national effort to raise awareness of one of the most common cancers affecting men. The recognition comes as a timely reminder for Delaware men and their families: prostate health deserves attention, and early detection saves lives.
men will be diagnosed with prostate cancer during their lifetime, according to national health data.1
Why Does Prostate Cancer Awareness Month Matter?
Prostate cancer is one of the most commonly diagnosed cancers among men in the United States, yet it is also one of the most treatable when caught early. Statewide recognitions like Senate Concurrent Resolution 195 help open the door to conversations that many men and families put off, conversations about screening, family history, and proactive health decisions.
At Delaware Imaging Network, we are proud to support this statewide effort to increase awareness and encourage men across Delaware to take a proactive step toward their long-term health.
What Is Enhanced Prostate Screening (EPS)?
For men age 45 and older, Enhanced Prostate Screening (EPS) is helping to advance prostate cancer detection through imaging that is fast, accurate, and non-invasive. EPS combines advanced AI technology with a comprehensive clinical review process to enhance the accuracy of prostate MRI screenings, supporting earlier detection and more informed care decisions for patients and their physicians.
Key Benefits of EPS at Delaware Imaging Network
- Noninvasive imaging — no biopsy required to screen
- AI-enhanced accuracy paired with expert clinical review
- Fast results to support timely, informed decisions
- No physician referral needed — patients can self-refer
Early Detection Can Change Outcomes
When prostate cancer is identified at an earlier, more treatable stage, patients and physicians have more options and more time to make informed care decisions. That is the core purpose behind Enhanced Prostate Screening, giving men a proactive, accessible way to monitor their prostate health before symptoms arise.
You Can Self-Refer — No Referral Required
One of the most significant advantages of EPS is accessibility. Men aged 45 and older do not need a physician referral to schedule their screening. You can self-refer directly with Delaware Imaging Network and take a proactive step toward your health today.
Ready to prioritize your prostate health this September?
About Delaware Imaging Network
Delaware Imaging Network is committed to advancing accessible, accurate diagnostic imaging across the state. Through initiatives like Enhanced Prostate Screening, we're helping Delaware men take a proactive approach to their health with technology designed for earlier, more informed care decisions.
Sources
- American Cancer Society